Benign oligemia despite a malignant MRI profile in acute ischemic stroke. by Bang, Oh Young et al.
UCLA
UCLA Previously Published Works
Title
Benign oligemia despite a malignant MRI profile in acute ischemic stroke.
Permalink
https://escholarship.org/uc/item/8wk0d080
Journal
Journal of clinical neurology (Seoul, Korea), 6(1)
ISSN
1738-6586
Authors
Bang, Oh Young
Lee, Kwang Ho
Kim, Suk Jae
et al.
Publication Date
2010-03-26
DOI
10.3988/jcn.2010.6.1.41
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
 Copyright © 2010 Korean Neurological Association  41
Print ISSN 1738-6586 / On-line ISSN 2005-5013
10.3988/jcn.2010.6.1.41
CASE REPORT
J Clin Neurol 2010;6:41-45
Introduction
One of the major concerns in the management of patients 
with acute ischemic stroke is the identification of individuals 
who are unlikely to benefit or may even be harmed by recan-
alization therapy. The Diffusion and Perfusion Imaging Eval-
uation for Understanding Stroke Evolution (DEFUSE) trial-
ists recently demonstrated that baseline MRI patterns may be 
useful for identifying subgroups of patients likely to benefit 
from reperfusion therapies and also those unlikely to benefit 
or potentially even be harmed.1 The results of that seminal 
study are underscored by the relatively large and well-de-
signed nature of the multicenter prospective clinical stroke 
trial providing a simple but valuable MRI categorization 
scheme of profiles (mismatch vs. matched vs. small vs. malig-
nant) that are strongly associated with clinical outcomes after 
reperfusion therapy. They defined a “malignant profile” as a 
baseline diffusion-weighted imaging (DWI) lesion of 100 mL 
or more and/or a perfusion-weighted imaging (PWI) lesion of 
100 mL or a Tmax delay (time to peak after deconvolution) of 
8 seconds or longer, which was associated with a low rate of 
favorable clinical responses and a high risk of fatal symp-
tomatic intracranial hemorrhage in patients following reper-
fusion therapies. 
We describe two clinical vignettes of acute middle cerebral 
artery (MCA) occlusion where the malignant MRI profile led 
to a favorable clinical outcome, emphasizing the critical role of 
collateral pathophysiology and highlighting potential pitfalls of 
this malignant MRI pattern derived from time parameters.
Case Report
Case 1
A 56-year-old right-handed Korean woman was sitting after 
having breakfast when she suddenly experienced left arm 
and leg weakness and dysarthria. On hospital arrival, her 
NIH Stroke Scale (NIHSS) score was 7 points (arm, 1; leg, 1; 
dysarthria, 1; face, 2; and neglect, 2). Prior vascular risk factors 
included hypertension, and she was receiving ongoing treat-
ment with three medications. Other relevant medical history 
included right thalamic hemorrhage and subarachnoid hem-
orrhage treated with craniotomy and aneurysm clipping 5 
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years earlier. Digital subtraction angiography at that time re-
vealed mild atherosclerosis without hemodynamically signif-
icant intracranial stenoses. 
Precontrast and triphasic postcontrast CT scans to obtain 
sequential images of the early, middle, and late phases ob-
tained using a previously reported method2 showed calcifica-
tion and total occlusion of the right proximal MCA, with a 
zone of perfusion abnormalities in the right hemisphere with 
complete irrigation of the ischemic bed via slow leptomenin-
geal collaterals evident on middle- and late-phase images 
(Fig. 1). MRI performed at 4 hours after symptom onset re-
vealed multiple acute small cortical infarcts on DWI. Dy-
namic susceptibility-enhanced PWI was performed utilizing 
postprocessing software to generate standard parametric per-
fusion images, including Tmax maps. Mismatch between 
perfusion and diffusion data was evident, yet a malignant 
profile (DWI lesion, 1.5 mL; Tmax >2 sec, 382 mL; Tmax >8 
sec, 100 mL) was identified (Fig. 1). A provisional diagnosis 
of acute thromboembolic infarcts originating from proximal 
MCA atherosclerosis was established, and the patient was 
treated with anticoagulation. Her laboratory tests, electrocar-
diogram, and transesophageal echocardiogram were unre-
markable, without suspicion of an alternative stroke etiology. 
Follow-up MRI was performed on the 8th and 90th days 
after symptom onset (Fig. 2). Severe perfusion defects were 
persistently observed but improved on days 8 (Tmax >2 sec, 
319 mL; Tmax >8 sec, 81 mL) and 90 (Tmax >2 sec, 233 mL; 
Tmax >8 sec, 6 mL). Despite the presumed ominous/malig-
nant MRI profile, no new lesions were observed on days 8 
(DWI) and 90 [fluid-attenuated inversion recovery (FLAIR) 
MRI]. Serial time-of-flight MR angiography showed signal 
loss in the right MCA suggesting persistent arterial occlusion 
(Fig. 2C) of the proximal MCA. Her initial NIHSS score of 7 
points decreased to 2 points on day 8 and to 0 points on day 
90 after symptom onset.
Case 2 
A 40-year-old right-handed Korean man awoke early in the 
morning with left hemiparesis and dysarthria. On hospital ar-
rival, his NIHSS score was 11 (consciousness, 2; arm, 2; leg, 
1; face, 2; dysarthria, 1; ataxia, 1; and neglect, 2). Vascular 
risk factors including hypertension were treated with medi-
cations. 
MRI performed 4 hours after symptom onset revealed mul-
tiple acute cortical and basal ganglia infarcts on DWI (Fig. 
3). A more extensive perfusion abnormality with mismatch 
was noted throughout the right MCA distribution (DWI le-
sion, 12.1 mL; Tmax >2 sec, 227 mL; Tmax >8 sec, 123 mL), 
DWI
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Fig. 1. MRI and CT angiography findings for patient 1 obtained on admission. DWI: diffusion-weighted imaging, FLAIR: fluid-attenuated in-
version recovery, CBV: cerebral blood volume.
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(A) 8th day after onset
(B) 90th day after onset
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Fig. 2. Follow-up MRI and MR angiography findings for patient 1. DWI: diffusion-weighted imaging, FLAIR: fluid-attenuated inversion recovery. 
fulfilling the criteria for a malignant profile. A cerebral an-
giogram performed immediately after MRI demonstrated oc-
clusive thrombus at the distal M1 segment of the right MCA 
and good leptomeningeal collateral perfusion. Recanaliza-
tion with intra-arterial thrombolysis at 6 hours after the time 
last known well resulted in complete reperfusion [Thrombol-
ysis In Cerebral Infarction (TICI) 3]. Clinical improvement 
was evident by the NIHSS score decreasing to 4 points at 4 
hours post procedure.  
Cardiac monitoring and transesophageal echocardiogram 
showed no evidence of a proximal cardioembolic source or 
aortic arch atherosclerosis. No new lesions were evident in 
MRI performed on days 7 and 90. The NIHSS score was 0 on 
day 90.
Discussion
These two case examples demonstrate the limitations in us-
ing a time-domain parameter such as Tmax to unequivocally 
define a malignant MRI profile that portends an unfavorable 
clinical course. Collateral perfusion of the ischemic territory 
may be characterized by delay, yet dispersion is also an influ-
ential feature. PWI data may be analyzed in several ways to 
yield relative or quantitative values,3 each of which reflect a 
particular aspect of the collateral perfusion. Time-domain 
parameters including the mean transit time (MTT; first move-
ment of the signal intensity curve), time to peak, and Tmax 
have been increasingly used to determine a diffusion-perfu-
sion mismatch.4 Tmax may be a sensitive PWI parameter for 
detecting an ischemic penumbra and core;5 Tmax thresholds 
of 6-8 sec were previously found to be optimally predictive 
of core infarcted tissue at 7 days.5 Several recent and ongo-
ing clinical trials evaluating the effects of reperfusion thera-
pies have based penumbral definitions on the Tmax delay.1,4,6 
However, using such time-domain perfusion parameters may 
have considerable drawbacks in certain scenarios. The pa-
tients described in this report had a malignant MRI profile 
based on the DEFUSE definitions that employ Tmax. In the 
DEFUSE trial, such “malignant” cases did not attain a favor-
able clinical outcome after early reperfusion; instead, early 
reperfusion was associated with fatal intracranial hemor-
rhage. Our cases did not develop intracranial hemorrhage or 
any derangement of the blood-brain barrier as measured with 
T2*-permeability MRI.7 Both cases resulted in optimal clini-
cal outcomes on day 90, including one case with benign oli-
gemia (case 1) and the other case treated with reperfusion 
therapy (case 2). Other perfusion parameters that more di-
rectly reflect the hemodynamic milieu in the ischemic terri-
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tory suggested that these areas of Tmax delay manifested 
low perfusion hyperemia or benign oligemia. Such areas of 
benign oligemia were not necessarily destined for infarction 
or prone to hemorrhage despite the severe Tmax delay. Prom-
inent dispersion and relative preservation or augmentation of 
the cerebral blood volume (CBV) sustained the ischemic re-
gions in both cases. 
Tmax solely provides an estimate of the delay in bolus ar-
rival time between the arterial input function and a given 
voxel, without describing the hemodynamic status of the tis-
sue itself.8 Limitations of PWI have previously been de-
scribed in patients with moyamoya syndrome, which is a 
model of chronic occlusion;9 long delays in perfusion were 
observed regardless of the presence or absence of clinical 
symptoms. The presence of collaterals can introduce both 
delay and dispersion in the bolus of contrast agent, limiting 
quantification of PWI data based on normal arterial inflow 
assumptions.9,10 However, such delay and dispersion features 
may reflect important vascular pathophysiology such as sus-
tained CBV in downstream regions due to collateral perfu-
sion. Compared to chronic hemodynamic insufficiency, there 
has been relatively little attention on the role of pretreatment 
collateral circulation in patients with acute ischemic stroke 
(A) MRI on admission (C) Angiogram
DWI
Tmax
(B) 7th day DWI
(D) 90th day FLAIR
Post-intra-arterial
thrombolysis
Fig. 3. MRI and angiography findings for patient 2. DWI: diffusion-weighted imaging, FLAIR: fluid-attenuated inversion recovery. 
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who are candidates for recanalization therapy.11 Atheroscle-
rotic occlusion in the present cases may have accentuated the 
role of collateral circulation and the relative importance of 
dispersion or CBV, beyond the simplistic measure of Tmax 
delay alone. Inherent delay and dispersion of the collateral 
perfusion may also cause errors in deconvolution estimates, 
underestimating cerebral blood flow and overestimating or 
exaggerating time-domain parameters such as MTT and 
Tmax.10 This may have been responsible for the severe Tmax 
delays in both of our cases being falsely interpreted as an isch-
emic core rather than benign oligemia. Such false interpreta-
tion of PWI findings may have obscured the prognosis in case 
1 (benign oligemia), and the dramatic clinical benefit of 
thrombolysis may have been incorrectly overlooked in case 2.  
A multiparameter approach has been suggested for defin-
ing the PWI abnormalities, combining data from relative ce-
rebral blood flow, regional CBV, and time-domain maps,12 
whereas others have advocated simply using time-domain 
PWI parameters as estimates of tissue at risk because of cur-
rent limitations of non-time-domain PWI parameters with 
conventional dynamic susceptibility contrast techniques.6 It 
has recently been demonstrated that the apparent perfusion 
lesion size differed markedly depending on which of 10 dif-
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ferent PWI postprocessing methods were applied.3 Our pres-
ent cases suggest that in certain clinical settings of acute 
ischemic stroke, time-domain PWI parameters should be in-
terpreted with caution, and a non-time-domain PWI parame-
ter may be needed,12 such as in populations with a high prev-
alence of atherosclerosis (e.g., Asian) or in patients with pre-
sumed atherosclerotic stroke and those with prominent colla-
terals at the time of PWI data acquisition. Further prospective 
studies should investigate the accuracy of penumbral estima-
tion under these conditions.   
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